LACTOSE, UNSPECIFIED FORM
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 342.0 | -5.4 | 8 | 11 | 190.0 | 4 | 1.0 |
- UNII
- J2B2A4N98G
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Powder, For Solution | |
| Buccal | Tablet | 183.3MG |
| Buccal/sublingual | Tablet | 296.7MG |
| Im - Iv | Injection | 20.35% |
| Im - Iv | Powder, For Injection Solution | |
| Im - Iv - Sc | Injection | |
| Im - Iv - Sc | Powder, For Injection Solution | 13.3% |
| Inhalation | Capsule | 20MG |
| Inhalation | Capsule, Hard Gelatin | 25MG |
| Inhalation | Powder | 9% |
| Intracavitary | Powder, For Injection Solution, Lyophilized | 19.38% |
| Intramuscular | Injection | |
| Intramuscular | Powder, For Injection Solution | 2% |
| Intramuscular | Powder, For Injection Solution, Lyophilized | 1% |
| Intravenous | Injection | 50% |
| Intravenous | Powder, For Injection Solution | 5% |
| Intravenous | Powder, For Injection Solution, Lyophilized | 1% |
| Iv(Infusion) | Injection | |
| Iv(Infusion) | Powder, For Injection Solution | |
| Iv(Infusion) | Solution, Injection | 0.45% |
| Oral | Capsule | 530MG |
| Oral | Capsule, Coated Pellets | 102.44MG |
| Oral | Capsule, Delayed Action, Enteric Coated | |
| Oral | Capsule, Enteric Coated Pellets | 135.2MG |
| Oral | Capsule, Hard Gelatin | 100MG |
| Oral | Capsule, Soft Gelatin | 115.75MG |
| Oral | Capsule, Sustained Action | 120MG |
| Oral | Concentrate | |
| Oral | Granule, For Suspension | |
| Oral | Solution | 11.21% |
| Oral | Tablet | 2217MG |
| Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | 117.7MG |
| Oral | Tablet, Coated | 332.05MG |
| Oral | Tablet, Controlled Release | 0.02MG |
| Oral | Tablet, Delayed Action | 92.02MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 209MG |
| Oral | Tablet, Delayed Release | |
| Oral | Tablet, Extended Release | 122.99MG |
| Oral | Tablet, Film Coated | 590MG |
| Oral | Tablet, Multilayer, Extended Release | 122MG |
| Oral | Tablet, Repeat Action | 153.2MG |
| Oral | Tablet, Sustained Action | 400MG |
| Oral | Tablet, Sustained Action, Film Coated | 51.1MG |
| Oral | Tablet, Sustained Release, Film Coated | 38.75MG |
| Oral-20 | Tablet | 70.7MG |
| Oral-21 | Tablet | 89.28MG |
| Oral-28 | Tablet | 179.2MG |
| Rectal | Solution | 8% |
| Rectal | Tablet | 20MG |
| Subcutaneous | Powder, For Injection Solution | 2% |
| Subcutaneous | Powder, For Injection Solution, Lyophilized | 0.5% |
| Sublingual | Tablet | 175.92MG |
| Topical | Emulsion, Cream | |
| Transdermal | Film, Controlled Release | 675MG |
| Transdermal | Ointment | 18.9% |
| Vaginal | Emulsion, Cream | 3% |
| Vaginal | Suppository | |
| Vaginal | Tablet | 1013MG |